Through collaboration, the Center for Quantitative Metabolic Research will help improve Cleveland Clinic’s standing as a leader for Type 2 diabetes and obesity research.
Salivary miRNAs Show Potential as Noninvasive Biomarkers of Hepatocellular Carcinoma
MicroRNA molecules associated with hepatocellular carcinoma are present and detectable in saliva and hold promise as highly sensitive and noninvasive biomarkers of the disease, Cleveland Clinic investigators have found.
New Analysis of Old Trial Results Offers Insights Into Personalized Care for Type 2 Diabetes
New research indicates a previously unrecognized genetic subtype of patients with type 2 diabetes at high risk for cardiovascular disease who may benefit from intensive glycemia treatment.